Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study Of The Combination Of Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma

NCT07251413 is registered in ClinicalTrials.gov with Instituto Oncológico Dr Rosell as lead sponsor.

NCT NCT07251413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07251413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study Of The Combination Of Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Lead sponsor
Instituto Oncológico Dr Rosell
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 22, 2025
Completion date
December 31, 2028
Enrollment
18 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous basal cell carcinoma